BinDel: Detecting Clinically Relevant Fetal Genomic Microdeletions Using Low‐Coverage Whole‐Genome Sequencing‐Based NIPT
Prenatal Diagnosis · 2025-03 · 45 (3) · 352-361
DOI: 10.1002/pd.6758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, online erschienen am 07.02.2025. Verfasst von Priit Paluoja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. Hauptthemen laut MEDLINE: Whole Genome Sequencing, Noninvasive Prenatal Testing, Software, Chromosome Deletion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020 Framework Programme, Ettevõtluse Arendamise Sihtasutus, Eesti Teadusagentuur.
Abstract (Originalsprache)
Objective
Clinically pathogenic chromosomal microdeletions cause severe genetic disorders. Motivated by the absence of reliable screening of microdeletions during the first‐trimester screening, we developed BinDel, a software tool to determine the risk of clinically relevant pathogenic fetal microdeletions from low‐coverage whole‐genome‐sequencing (WGS) based NIPT data.
Methods
We developed novel computational software that employs a targeted approach with region‐specific normalisation and calling procedures to detect microdeletion risk in predefined chromosomal regions. The software was developed using 500 NIPT samples and validated on an additional 84 samples, including 34 rare fetal microdeletions confirmed both pre‐ and postnatally.
Results
BinDel correctly identified 30 out of 34 samples with microdeletions, with only three false‐positive calls among 50 euploid samples, all latter originating from the Williams‐Beuren and Prader‐Willi/Angelman syndrome‐associated microdeletion regions.
Conclusions
We confirmed BinDel's feasibility for integrating microdeletion analysis into routine NIPT protocol. This work stands as a unique contribution to prenatal microdeletion screening, providing a novel and readily available software tool that was validated with a large set of actual microdeletion samples, positioning it as the first of its kind in the field. BinDel is available at https://github.com/seqinfo/BinDel .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
- Celvia CC AS, Tartu, Estonia.
- Department of Human Genetics, KU Leuven, Leuven, Belgium.
- Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
- Institute of Genomics, University of Tartu, Tartu, Estonia.
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
ORCID-Profile: Priit Paluoja, Joris Robert Vermeesch, Priit Palta
Förderung
- Horizon 2020 Framework Programme
- Ettevõtluse Arendamise Sihtasutus
- Eesti Teadusagentuur
- Haridus- ja Teadusministeerium
Zitieren
APA
Paluoja, P., Jatsenko, T., Teder, H., Krjutškov, K., Vermeesch, J. R., Salumets, A., & Palta, P. (2025). BinDel: Detecting Clinically Relevant Fetal Genomic Microdeletions Using Low‐Coverage Whole‐Genome Sequencing‐Based NIPT. Prenatal Diagnosis, 45(3), 352-361. https://doi.org/10.1002/pd.6758
Vancouver
Paluoja P, Jatsenko T, Teder H, Krjutškov K, Vermeesch JR, Salumets A, et al. BinDel: Detecting Clinically Relevant Fetal Genomic Microdeletions Using Low‐Coverage Whole‐Genome Sequencing‐Based NIPT. Prenatal Diagnosis. 2025;45(3):352-361. doi:10.1002/pd.6758
BibTeX
@article{Paluoja2025,
author = {Paluoja, Priit and Jatsenko, Tatjana and Teder, Hindrek and Krjutškov, Kaarel and Vermeesch, Joris Robert and Salumets, Andres and Palta, Priit},
title = {BinDel: Detecting Clinically Relevant Fetal Genomic Microdeletions Using Low‐Coverage Whole‐Genome Sequencing‐Based NIPT},
journal = {Prenatal Diagnosis},
year = {2025},
volume = {45},
number = {3},
pages = {352--361},
doi = {10.1002/pd.6758}
}
EUVIMED